Clinical Trends for May 2016

Ryan Syrek


May 27, 2016

Each week, we identify one top search term, speculate as to what caused its popularity, and provide an infographic on a related condition. If you have thoughts about what's trending and why, feel free to share them with us on Twitter or Facebook!

Clinical Trend of the Week (May 21-27): Glioblastoma

Glioblastoma brain tumors may have found a new enemy. According to new findings, a novel combination of a cytomegalovirus (CMV)-targeted dendritic cell (DC) vaccine results in significant improvements in overall survival in phase 2 clinical trials. After preconditioning with a tetanus booster, CMV pp65-DC vaccines showed encouraging survival data in a small study. So far, the CMV-targeting vaccine has demonstrated a good safety profile and significant increases in median progression-free survival (25.3 mo) and overall survival (41.1 mo). Physicians looking to provide the best treatment possible to patients who typically have a short clinical history certainly increased searches for this condition this week.

For more information on glioblastoma, read here.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.